{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T07:46:31Z","timestamp":1775720791511,"version":"3.50.1"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T00:00:00Z","timestamp":1775692800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T00:00:00Z","timestamp":1775692800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Cardiol Rep"],"DOI":"10.1007\/s11886-026-02364-6","type":"journal-article","created":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T06:53:39Z","timestamp":1775717619000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Aspirin or Clopidogrel? Rethinking the Default Strategy for Secondary Prevention of Coronary Artery Disease"],"prefix":"10.1007","volume":"28","author":[{"given":"Jorge Chiquie","family":"Borges","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Khush","family":"Dadhania","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,4,9]]},"reference":[{"key":"2364_CR1","unstructured":"Brown JC, Gerhardt TE, Kwon E. Risk Factors for Coronary Artery Disease. PubMed. Treasure Island (FL): StatPearls Publishing; 2023. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/32119297\/"},{"key":"2364_CR2","doi-asserted-by":"publisher","unstructured":"Palasubramaniam J, Wang X, Peter K. Myocardial infarction\u2014from atherosclerosis to thrombosis. arteriosclerosis, thrombosis, and vascular biology. 2019;39(8). Available from: https:\/\/www.ahajournals.org\/doi\/https:\/\/doi.org\/10.1161\/ATVBAHA.119.312578","DOI":"10.1161\/ATVBAHA.119.312578"},{"key":"2364_CR3","doi-asserted-by":"crossref","unstructured":"Patrono C, Morais J, Baigent C, Collet JP, Fitzgerald D, Halvorsen S et al. Antiplatelet agents for the treatment and prevention of coronary atherothrombosis. J Am Coll Cardiol. 2017;70(14):1760\u201376. Available from: https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/28958334","DOI":"10.1016\/j.jacc.2017.08.037"},{"key":"2364_CR4","doi-asserted-by":"crossref","unstructured":"Nil O. Antiplatelet therapy in heart disease. Rev Cardiovasc Med. 2025 [cited 2025 Sep 9];26(6). Available from: https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC12230833\/","DOI":"10.31083\/RCM36522"},{"key":"2364_CR5","doi-asserted-by":"publisher","unstructured":"Libby P, Theroux P. Pathophysiology of coronary artery disease. Circulation. 2005;111(25):3481\u20138. Available from: https:\/\/www.ahajournals.org\/doi\/full\/https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.105.537878","DOI":"10.1161\/CIRCULATIONAHA.105.537878"},{"key":"2364_CR6","doi-asserted-by":"publisher","unstructured":"Badimon L, Vilahur G. Thrombosis formation on atherosclerotic lesions and plaque rupture. J Int Med. 2014;276(6):618\u201332. Available from: https:\/\/onlinelibrary.wiley.com\/doi\/https:\/\/doi.org\/10.1111\/joim.12296","DOI":"10.1111\/joim.12296"},{"key":"2364_CR7","doi-asserted-by":"crossref","unstructured":"CAPRIE Steering Committee. A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). The Lancet. 1996;348(9038):1329\u201339. Available from: https:\/\/www.thelancet.com\/journals\/lancet\/article\/PIIS0140-6736(96)09457-3\/fulltext","DOI":"10.1016\/S0140-6736(96)09457-3"},{"key":"2364_CR8","unstructured":"Arif H, Aggarwal S. Salicylic acid (Aspirin). National Institute of Health. StatPearls Publishing; 2023. Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK519032\/"},{"key":"2364_CR9","doi-asserted-by":"crossref","unstructured":"Angiolillo DJ, Bhatt DL, Gurbel PA, Jennings LK. Advances in Antiplatelet Therapy: Agents in Clinical Development. 2009;103(3):40A51A. Available from: https:\/\/www.ajconline.org\/article\/S0002-9149(08)02032-8\/abstract","DOI":"10.1016\/j.amjcard.2008.11.023"},{"key":"2364_CR10","unstructured":"Dean L. Clopidogrel Therapy and CYP2C19 Genotype. Nih.gov. National Center for Biotechnology Information (US); 2022. Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK84114\/"},{"key":"2364_CR11","doi-asserted-by":"crossref","unstructured":"Neumann FJ, Sousa-Uva M, Ahlsson A, Alfonso F, Banning AP, Benedetto U et al. 2018 ESC\/EACTS Guidelines on myocardial revascularization. Eur Heart J. 2018;40(2):87\u2013165. Available from: https:\/\/academic.oup.com\/eurheartj\/article\/40\/2\/87\/5079120","DOI":"10.1093\/eurheartj\/ehy855"},{"key":"2364_CR12","doi-asserted-by":"crossref","unstructured":"Antithrombotic Trialists\u2019 Collaboration. Collaborative meta-analysis of randomized trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high-risk patients. BMJ. 2002;324(7329):71\u201386. Available from: https:\/\/www.bmj.com\/content\/324\/7329\/71","DOI":"10.1136\/bmj.324.7329.71"},{"key":"2364_CR13","doi-asserted-by":"crossref","unstructured":"Antithrombotic Trialists\u2019 (ATT) Collaboration. Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomized trials. The Lancet. 2009;373(9678):1849\u201360. Available from: https:\/\/www.thelancet.com\/journals\/lancet\/article\/PIIS0140-6736(09)60503-1\/fulltext","DOI":"10.1016\/S0140-6736(09)60503-1"},{"key":"2364_CR14","unstructured":"Knuuti J, Wijns W, Saraste A, Capodanno D, Barbato E, Funck-Brentano C et al. 2019 ESC guidelines for the diagnosis and management of chronic coronary syndromes. Eur Heart J. 2019;41(3):407\u201377. Available from: https:\/\/academic.oup.com\/eurheartj\/article\/41\/3\/407\/5556137?login=false"},{"key":"2364_CR15","doi-asserted-by":"crossref","unstructured":"Koo BK, Kang J, Park KW, Rhee TM, Yang HM, Won KB et al. Aspirin versus clopidogrel for chronic maintenance monotherapy after percutaneous coronary intervention (HOST-EXAM): an investigator-initiated, prospective, randomised, open-label, multicentre trial. Lancet (London, England). 2021;397(10293):2487\u201396. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/34010616\/","DOI":"10.1016\/S0140-6736(21)01063-1"},{"key":"2364_CR16","doi-asserted-by":"publisher","unstructured":"Kang J, Park KW, Lee H, Hwang D, Yang HM, Rha SW et al. Aspirin versus clopidogrel for long-term maintenance monotherapy after percutaneous coronary intervention: The HOST-EXAM extended study. Circulation. 2023;147(2):108\u201317. Available from: https:\/\/www.ahajournals.org\/doi\/https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.122.062770","DOI":"10.1161\/CIRCULATIONAHA.122.062770"},{"key":"2364_CR17","unstructured":"Valgimigli M, Choi KH, Giacoppo D, Gragnano F, Kimura T, Watanabe H et al. Clopidogrel versus aspirin for secondary prevention of coronary artery disease: a systematic review and individual patient data meta-analysis. The Lancet. 2025; Available from: https:\/\/www.thelancet.com\/journals\/lancet\/article\/PIIS0140-6736(25)01562-4\/abstract"},{"key":"2364_CR18","doi-asserted-by":"publisher","unstructured":"Watanabe H, Masahiro Natsuaki, Morimoto T, Yamamoto K, Obayashi Y, Nishikawa R et al. Aspirin versus Clopidogrel monotherapy after percutaneous coronary intervention: 1-year follow-up of the STOPDAPT-3 trial. Eur Heart J. 2024; Available from: https:\/\/academic.oup.com\/eurheartj\/advance-article\/doi\/https:\/\/doi.org\/10.1093\/eurheartj\/ehae617\/7745594","DOI":"10.1093\/eurheartj\/ehae617\/7745594"},{"key":"2364_CR19","doi-asserted-by":"publisher","unstructured":"Spartalis M, Siasos G. Challenging the Divinity of Aspirin Monotherapy for Secondary Prevention of Cardiovascular Disease. JACC: Asia. 2023;3(2):208\u201310. Available from: https:\/\/www.jacc.org\/doi\/https:\/\/doi.org\/10.1016\/j.jacasi.2023.01.002","DOI":"10.1016\/j.jacasi.2023.01.002"},{"key":"2364_CR20","doi-asserted-by":"crossref","unstructured":"Choi KH, Park YH, Lee JY, Jeong JO, Kim CJ, Yun KH et al. Efficacy and safety of clopidogrel versus aspirin monotherapy in patients at high risk of subsequent cardiovascular event after percutaneous coronary intervention (SMART-CHOICE 3): a randomised, open-label, multicentre trial. The Lancet. 2025; Available from: https:\/\/www.sciencedirect.com\/science\/article\/abs\/pii\/S0140673625004490","DOI":"10.1016\/S0140-6736(25)00449-0"},{"key":"2364_CR21","doi-asserted-by":"publisher","unstructured":"Liu D, Xu WP, Xu H, Zhao L, Dao Qun Jin. Efficacy and safety of clopidogrel versus aspirin monotherapy for secondary prevention in patients with coronary artery disease: a meta-analysis. Front Cardiovasc Med. 2023;10. Available from: https:\/\/www.frontiersin.org\/journals\/cardiovascular-medicine\/articles\/https:\/\/doi.org\/10.3389\/fcvm.2023.1265983\/full","DOI":"10.3389\/fcvm.2023.1265983\/full"},{"key":"2364_CR22","doi-asserted-by":"crossref","unstructured":"Bellemain-Appaix A, Montalescot G. Clopidogrel for long-term secondary prevention after coronary artery stenting. J Am Coll Cardiol. 2024;83(1):32\u20134. Available from: https:\/\/www.sciencedirect.com\/science\/article\/pii\/S0735109723079901?via%3Dihub","DOI":"10.1016\/j.jacc.2023.11.004"},{"key":"2364_CR23","unstructured":"Kumar S. Clopidogrel vs. Aspirin: a new era in secondary prevention for coronary artery disease? Agappe.com. Agappe Diagnostics; 2025 [cited 2025 Dec 30]. Available from: https:\/\/www.agappe.com\/swiss_en\/blog-details\/clopidogrel-vs-aspirin-a-new-era-in-secondary-prevention-for-coronary-artery-disease.html?srsltid=AfmBOoq7rL9tsK10UEBGj6JhHP2LktIStmn75ytftsh5EnLlfmoK98Hl"},{"key":"2364_CR24","doi-asserted-by":"crossref","unstructured":"Abraham NS, Barkun AN, Sauer BG, Douketis J, Laine L, Noseworthy PA et al. American college of gastroenterology-canadian association of gastroenterology clinical practice guideline: management of anticoagulants and antiplatelets during acute gastrointestinal bleeding and the periendoscopic period. J Can Assoc Gastroenterol. 2022;5(2):100\u20131. Available from: https:\/\/journals.lww.com\/ajg\/fulltext\/2022\/04000\/american_college_of_gastroenterology_canadian.16.aspx","DOI":"10.1093\/jcag\/gwac010"},{"key":"2364_CR25","doi-asserted-by":"publisher","unstructured":"Bennett CL, Connors JM, Carwile JM, Moake JL, Bell WR, Tarantolo SR et al. Thrombotic thrombocytopenic purpura associated with clopidogrel. New Engl J Med. 2000;342(24):1773\u20137. Available from: https:\/\/www.nejm.org\/doi\/full\/https:\/\/doi.org\/10.1056\/NEJM200006153422402","DOI":"10.1056\/NEJM200006153422402"},{"key":"2364_CR26","unstructured":"Rao GH. Aspirin resistance: a fact or a myth? experimental & clinical cardiology. 2024;10(1):17. Available from: https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC2716223\/"},{"key":"2364_CR27","doi-asserted-by":"publisher","unstructured":"Angiolillo DJ, Fernandez-Ortiz A, Bernardo E, Alfonso F, Macaya C, Bass TA et al. Variability in individual responsiveness to clopidogrel. J Am Coll Cardiol. 2007;49(14):1505\u201316. Available from: https:\/\/www.jacc.org\/doi\/https:\/\/doi.org\/10.1016\/j.jacc.2006.11.044","DOI":"10.1016\/j.jacc.2006.11.044"},{"key":"2364_CR28","unstructured":"Lenk E, Spannagl M. Platelet function testing-guided antiplatelet therapy. EJIFCC. 2014 Feb 21 [cited 2025 Nov 24];24(3):90. Available from: https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC4975182\/"},{"key":"2364_CR29","doi-asserted-by":"publisher","unstructured":"Claassens DMF, Vos GJA, Bergmeijer TO, Hermanides RS, van \u2019t Hof AWJ, van der Harst P et al. A genotype-guided strategy for oral P2Y12 inhibitors in primary PCI. New Engl J Med. 2019;381(17):1621\u201331. Available from: https:\/\/www.nejm.org\/doi\/full\/https:\/\/doi.org\/10.1056\/NEJMoa1907096","DOI":"10.1056\/NEJMoa1907096"},{"key":"2364_CR30","doi-asserted-by":"crossref","unstructured":"Virani SS, Newby LK, Arnold SV, Bittner V, Brewer LC, Demeter SH et al. 2023 AHA\/ACC\/ACCP\/ASPC\/NLA\/PCNA guideline for the management of patients with chronic coronary disease: a report of the American Heart Association\/American College of Cardiology Joint Committee on Clinical Practice Guidelines. Circulation. 2023;148(9). Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/37471501\/","DOI":"10.1161\/CIR.0000000000001183"},{"key":"2364_CR31","doi-asserted-by":"publisher","unstructured":"Lawton JS, Tamis-Holland JE, Bangalore S, Bates ER, Beckie TM, Bischoff JM et al. 2021 ACC\/AHA\/SCAI guideline for coronary artery revascularization: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2022;145(3). Available from: https:\/\/www.ahajournals.org\/doi\/https:\/\/doi.org\/10.1161\/CIR.0000000000001038","DOI":"10.1161\/CIR.0000000000001038"},{"key":"2364_CR32","unstructured":"Valgimigli M, Bueno H, Byrne RA, Collet JP, Costa F, Jeppsson A et al. 2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS. Eur Heart J. 2017;39(3):213\u201360. Available from: https:\/\/academic.oup.com\/eurheartj\/article\/39\/3\/213\/4095043?login=false"},{"key":"2364_CR33","unstructured":"Antiplatelet Therapy for Secondary Prevention of Coronary Events - American College of Cardiology. American College of Cardiology. 2023 [cited 2025 Dec 30]. Available from: https:\/\/www.acc.org\/latest-in-cardiology\/journal-scans\/2023\/07\/19\/13\/35\/p2y12-inhibitor-or-aspirin?utm_source=chatgpt.com"},{"key":"2364_CR34","doi-asserted-by":"crossref","unstructured":"Oliva A, Cao D, Spirito A, Nicolas J, Pileggi B, Kamaleldin K et al. Personalized approaches to antiplatelet treatment for cardiovascular diseases: an umbrella review. Pharmacogenomics Personalized Med. 2023;16:973\u201390. Available from: https:\/\/www.dovepress.com\/personalized-approaches-to-antiplatelet-treatment-for-cardiovascular-d-peer-reviewed-fulltext-article-PGPM","DOI":"10.2147\/PGPM.S391400"},{"key":"2364_CR35","doi-asserted-by":"publisher","unstructured":"Pereira NL, Rihal C, Lennon R, Marcus G, Shrivastava S, Bell MR et al. Effect of CYP2C19 genotype on ischemic outcomes during oral P2Y12 inhibitor therapy. JACC Cardiovasc Interv. 2021;14(7):739\u201350. Available from: https:\/\/www.jacc.org\/doi\/https:\/\/doi.org\/10.1016\/j.jcin.2021.01.024","DOI":"10.1016\/j.jcin.2021.01.024"},{"key":"2364_CR36","doi-asserted-by":"crossref","unstructured":"Aggarwal D, Bhatia K, Chunawala ZS, Furtado RHM, Mukherjee D, Dixon SR et al. P2Y12 inhibitor versus aspirin monotherapy for secondary prevention of cardiovascular events: meta-analysis of randomized trials. Eur Heart J Open. 2022;2(2):oeac019. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/35919116\/","DOI":"10.1093\/ehjopen\/oeac019"},{"key":"2364_CR37","doi-asserted-by":"publisher","unstructured":"Tasoudis P, Kyriakoulis I, Sagris D, Diener HC, Ntaios G. Clopidogrel monotherapy versus aspirin monotherapy in patients with established cardiovascular disease: systematic review and meta-analysis. Thromb Haemost. 2022; Available from: https:\/\/www.thieme-connect.de\/products\/ejournals\/abstract\/https:\/\/doi.org\/10.1055\/a-1853-2952","DOI":"10.1055\/a-1853-2952"},{"key":"2364_CR38","doi-asserted-by":"crossref","unstructured":"Tan BE-X, Wong PY, Baibhav B, Thakkar S, Azhar AZ, Rao M et al. Clopidogrel versus aspirin monotherapy following dual antiplatelet therapy after percutaneous coronary intervention: a systematic review and meta-analysis. Curr Probl Cardiol. 2022;101174. Available from: https:\/\/www.sciencedirect.com\/science\/article\/abs\/pii\/S0146280622000718?via%3Dihub","DOI":"10.1016\/j.cpcardiol.2022.101174"},{"key":"2364_CR39","doi-asserted-by":"publisher","unstructured":"Sibbing D, Nicolas J, Spirito A, Vogel B, Cao D, Stipek W et al. Clopidogrel versus aspirin as monotherapy following dual antiplatelet therapy in patients with acute coronary syndrome receiving a drug-eluting stent: a systematic literature review and meta\u2010analysis. Clin Cardiol. 2024;47(9). Available from: https:\/\/onlinelibrary.wiley.com\/doi\/https:\/\/doi.org\/10.1002\/clc.24326","DOI":"10.1002\/clc.24326"}],"container-title":["Current Cardiology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11886-026-02364-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11886-026-02364-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11886-026-02364-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T06:54:03Z","timestamp":1775717643000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11886-026-02364-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,9]]},"references-count":39,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2364"],"URL":"https:\/\/doi.org\/10.1007\/s11886-026-02364-6","relation":{},"ISSN":["1534-3170"],"issn-type":[{"value":"1534-3170","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,9]]},"assertion":[{"value":"9 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This article does not contain any studies with human or animal subjects performed by any of the authors.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights and Informed Consent"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"47"}}